Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] stock went on an upward path that rose over 2.03% on Thursday, amounting to a one-week price increase of more than 7.09%. Over the last 12 months, BCRX stock dropped by -1.18%. The one-year Biocryst Pharmaceuticals Inc. stock forecast points
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] plunged by -$0.36 during the normal trading session on while it closed the day at $7.27. Biocryst Pharmaceuticals Inc. stock has also gained 12.02% of its value over the past 7 days. However, BCRX stock has inclined by 57.70% in
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] surged by $0.55 during the normal trading session on while it closed the day at $7.04. Biocryst Pharmaceuticals Inc. stock has also gained 9.83% of its value over the past 7 days. However, BCRX stock has inclined by 44.56% in
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] loss -1.11% or -0.07 points to close at $6.23 with a heavy trading volume of 2603359 shares. The daily chart for BCRX points out that the company has recorded 4.71% gains over the past six months. If we look at
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] price plunged by -5.15 percent to reach at -$0.35. The one-year BCRX stock forecast points to a potential upside of 54.0. The average equity rating for BCRX stock is currently 1.33, trading closer to a bullish pattern in the stock
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] closed the trading session at $6.57. The stocks have a year to date performance of 9.68 percent and weekly performance of -1.35 percent. The stock has been moved at 21.89 percent over the last six months. The stock has performed
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] stock went on an upward path that rose over 3.74% on Wednesday, amounting to a one-week price increase of more than 4.72%. Over the last 12 months, BCRX stock dropped by -22.29%. The one-year Biocryst Pharmaceuticals Inc. stock forecast points
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] price surged by 18.66 percent to reach at $1.0. The one-year BCRX stock forecast points to a potential upside of 54.57. The average equity rating for BCRX stock is currently 1.33, trading closer to a bullish pattern in the stock
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] surged by $0.82 during the normal trading session on while it closed the day at $5.27. Biocryst Pharmaceuticals Inc. stock has also gained 23.42% of its value over the past 7 days. However, BCRX stock has inclined by 2.53% in
Biocryst Pharmaceuticals Inc. [NASDAQ: BCRX] jumped around 0.44 points on Wednesday, while shares priced at $4.57 at the close of the session, up 10.65%. Compared to the average trading volume of 3.19M shares, BCRX reached a trading volume of 5157349 in the most recent trading
Copyright © 2024, Powered by Smart TechOne
